Kind of unfortunate timing to have to put out the 4C so close to funding, but it is what it is.
I like the fact major shareholders are the likely participants in the upcoming deal. Let's hope AstraZen also has a role to play - will represent significant validation of Jeremy's strategy going forward. Nonetheless the devil will be in the detail. I doubt this will be a long wait.
- Forums
- ASX - By Stock
- Ann: Appendix 4C - quarterly
Kind of unfortunate timing to have to put out the 4C so close to...
Featured News
Add ADR (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.65M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 73676 | 1.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.8¢ | 27 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 73676 | 0.018 |
3 | 590000 | 0.017 |
1 | 349980 | 0.016 |
5 | 607497 | 0.015 |
2 | 146425 | 0.014 |
Price($) | Vol. | No. |
---|---|---|
0.018 | 27 | 1 |
0.019 | 100000 | 1 |
0.020 | 494888 | 1 |
0.021 | 346000 | 1 |
0.022 | 304500 | 1 |
Last trade - 09.26am 05/07/2024 (20 minute delay) ? |
Featured News
ADR (ASX) Chart |
Day chart unavailable